Clinical Trial

Predicting the Metabolic Biomarkers Associated With Injury in Athletes

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
For elite athletes, sports injuries significantly impede the further enhancement of their competitive performance. Consequently, the significance of preventing, detecting, and addressing potential injury issues has become increasingly critical. Currently, the comprehensive evaluation of athletes' physical function and condition primarily depends on a range of physiological, biochemical, and immunological indicators. However, these methods have progressively exposed their limitations. As an advanced bioinformatics technology, omics research demonstrates unique advantages. By leveraging multi-omics research and analysis, it is possible to more accurately observe the physiological and biochemical changes that athletes undergo during training and competition, as well as their regulatory mechanisms. This approach can provide practical data, identify biomarkers that can warn of potential injuries, and offer precise guidance for training monitoring and injury prevention. It also provides a foundation for developing diverse, precise, and personalized sports programs and rehabilitation plans.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-16; most recent amendment 2026-04-22.
Status change: Not Yet Recruiting → Enrolling by Invitation 2026-02-10
Trial Details
NCT Number NCT06888635
Lead Sponsor Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Conditions Sports Medicine
Enrollment 60 participants
Start Date 2025-04-16
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-04-24